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mode chip designed in 130 nm CMOS technology [1]. We 
present results of a PET-ToF demonstrator scanner based on 
this ASIC and featuring a highly integrated readout and DAQ 
system. 
The Detector Module is composed of 8 matrices of 4x4 LYSO 
scintillating crystals, each with a size of 3.1 x 3.1 x 15 mm3. 
These matrices are optically coupled to 8 arrays of 
Hamamatsu TSV-MPPCs. The crystal matrices and associated 
MPPCs plug directly in the Frontend Boards forming a 
compact detecting unit with active area 59x29 mm2. The 
present results were obtained with a partially assembled ring 
(16 Modules) corresponding to 2048 SiPM readout channels. 
The Frontend board integrates two ASICs allowing the 
readout and digitization of 128 MPPC pixels. On-chip TDCs 
produce two time measurements allowing the determination 
of the event time and of the time-over-threshold. A 
Concentrator board reads the data from eight Frontend 
boards (1024 channels) and transmits assembled data frames 
through a serial link to the PCIe based DAQ board in the data 
acquisition PC.  
At present the PET-ToF demonstrator is fully assembled and 
in operation (Figure 1). We will report on the detector 
performance, including energy resolution, spatial resolution, 
time resolution and rate performance of the system. Images 
with phantoms will also be presented. 
 
 
Figure 1 - Flood histogram of the full scanner obtained 
with a Na22 point source. 
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The cell membrane not only functions as a physical barrier 
between the intracellular and extracellular space, it harbors 
critical components involved in receptor-ligand interactions, 
signal transduction and drug uptake. Targeting the cell 
membrane represents a novel strategy to improve anti-
cancer therapy. Our work focuses on two different 
approaches. The first involves lipid rafts. These are dynamic, 
cholesterol/sphingolipid-enriched microdomains within 
biological membranes, and play a crucial role in the 
induction of (apoptotic) cell death by radiation, pro-
apoptotic receptor agonists and synthetic alkyl-
phospholipids. 
The second approach addresses insufficient drug delivery into 
tumor cells, which represents a major limitation of cytostatic 
therapy. We found that co-formulation and co-administration 
of liposome-encapsulated chemotherapy and synthetic short-
chain sphingolipids (SCS) improves drug availability by 
enhancing intracellular drug uptake. Specific biophysical 
requirements of both the SCS (chain length and polarity) and 
chemotherapeutic agent (amphiphilicity) determine the 
optimal conditions for improved drug delivery. Doxorubicine 
and mitoxantrone are two frequently prescribed 
chemotherapeutic agents that benefit from this cell 
membrane-targeting approach. In vitro and in vivo studies 
demonstrate higher drug efficacy and/or lower toxicity in 
relevant tumor model systems. Mechanistic analyses 
demonstrate that SCS preferentially insert into tumor cell 
membranes enhancing the intrinsic capacity to translocate 
amphiphilic drugs.  
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Purpose: Modern radiotherapy is based on using small 
radiation fields and their segments. For clinical use they 
need to be verified by measurement. But measurement of 
small radiosurgery fields is very problematic task because of 
dosimetry challenges, such as loss of charged particle 
equilibrium, accurate positioning of detector and its small 
size. Purpose of this study is to assess new synthetic single 
crystal MicroDiamond PTW 60019 detector. Its dosimetry 
characteristics from the manufacturer and especially small 
size of its sensitive volume (0.004 mm3) make the detector 
promising tool for this task. 
Materials and Method: In this study basic dosimetry 
characteristics of MicroDiamond detector were verified in 
clinical linear accelerator photon and electron beams. 
Measurements involved short time stability and detector 
response dependence on dose rate, beam energy, 
temperature and angular dependence. In addition, 
measurement of relative output factors for Leksell Gamma 
Knife Perfexion was performed in order to test dosimeter 
performance for small fields. Collimator sizes 4 mm, 8 mm 
and 16 mm were used. Results obtained by this detector 
were compared with ELEKTA reference values and 
independent Monte Carlo Geant4 simulation. 
Results: Stabilization of detector response was always 
performed before starting measurement. For this purpose 40 
minutes irradiation in reference conditions was necessary 
(corresponding delivered dose was about 100 Gy). After this 
time the response was relatively stable with difference 
between maximum and minimum value 0.25% and standard 
deviation of all measurements 0.07% within an hour 
(normalized for this and all subsequent measurements to 
mean value of response). Dose rate dependence was 
measured for 6 different dose rates. Difference between 
maximum and minimum value was 0.24%. Energy dependence 
of detector was performed for 2 photon energies (6 and 18 
MV) and 5 electron energies (6-20 MeV). Difference between 
maximum and minimum photon beam values was 0.12%, for 
electron beams this difference was 4.54% with standard 
deviation of response values 1.62%. Results for temperature 
and angular dependence are not finalized yet. Finally, results 
of comparative measurement for relative output factors of 
the Leksell Gamma Knife for 4 and 8 mm collimators were 
0.831 and 0.900, respectively. These values are in a good 
agreement with vendor values (0.814 and 0.900) and Monte 
Carlo simulation. 
Conclusion: New MicroDiamond PTW 60019 detector appears 
to be a promising detector for relative output factor 
measurements in small radiosurgery fields. Verified 
dosimetric properties of the detector are in limits set by 
manufacturer. However, relatively long pre-irradiation 
process is necessary prior to measurement before the 
detector can produce reliable data. Further measurements 
will follow. This work was supported by CTU grant no. 
SGS15/217/OHK4/3T/14. 
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